Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4497L |
Amifampridine phosphate
BRN0110232,3,6-DAP,SC10,BRN 0110232,BRN-0110232,NSC 521760 |
||
Amifampridine is mainly used to treat many rare muscle diseases. In the United States, aminopyridine is being studied for the treatment of Lambert-Eaton myasmus syndrome (LEMS). Amifampridine is also used to treat many congenital myasthenia syndromes, par | |||
T23329 |
SC-10
|
Others | Others |
SC-10 is a Protein kinase C activator. | |||
T33749 |
NSC107392
NSC 107392,NSC-107392 |
||
NSC107392 is a substrate of ABCG2. | |||
T69141 |
NSC1008
|
||
NSC1008 is an inhibitor of the Ras Converting Enzyme 1 (Rce1) protease that disrupts Ras membrane localization in human cells. | |||
T12114 |
MSC1094308
|
p97 | Ubiquitination |
MSC1094308 is a reversible and allosteric inhibitor of the type II AAA ATPase. | |||
T69893 |
NSC109131
|
||
NSC109131 is an inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1). | |||
T28201 |
NSC1011
NSC 1011,NSC-1011 |
||
NSC1011 is an inhibitor of ras converting enzyme 1 (Rce1). | |||
T25884 |
NSC103054
NSC-103054,NSC 103054 |
||
NSC103054 is an ABCG2 transporter function inhibitor. | |||
T24548 |
NSC10010 hydrochloride
NSC#10010,NSC 10010,NSC# 10010,NSC#-10010,NSC-10010 |
||
NSC10010 hydrochloride is an effective growth inhibitor for gammaherpesvirus-associated B-lymphomas. It acts through activation of both the NF-κB and c-Myc-mediated signaling pathways. |